Navigation Links
Covance Decides to Pursue Its Original Preclinical Strategy in China
Date:9/29/2008

PRINCETON, N.J., Sept. 29 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) announced today that it will no longer pursue a 50-50 joint venture with WuXi Pharmatech to provide preclinical contract research services in China.

"We expect China will become an attractive region for outsourced drug development services over the longer-term. To seize this opportunity, we will pursue our original strategy to build our own world-class preclinical facility in the region and aggressively compete as the global market leader in a business we know very well. We plan to build a comprehensive preclinical capability that matches the high-quality facilities and scientific teams our clients have grown to trust in Europe and North America," said Joe Herring, Covance chairman and chief executive officer. "Once built, the preclinical facility will complement our existing Phase II/III clinical development, central laboratory and our new bioanalytical capability in China and allow us to enjoy the full financial benefits of further leveraging Covance's high- quality brand and drug development experience into Asia."

About Covance

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 9,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.

Statements contained in this press release, which are not historical facts, such as statements about the nature, scope and timing and benefits of the planned joint venture as well as the attractiveness of China for delivering outsourced discovery and development services, the growth of the China market and advantages of conducting preclinical research and develo
'/>"/>

SOURCE Covance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call
2. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
3. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
4. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
5. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
6. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
7. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
8. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
9. Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies
10. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
11. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Austria, November 9 For more than... working on the development of a,Brain-Computer In...nel,between the brain and a computer. Such a syste...cate or to control devices in their environment ju...patients have been supervised by,the researchers t...
(Date:11/9/2009)... Four of the top 10 pharmaceutical giants use D...to Health Canada. Datafarm’s announcement co... DIA Annual Meeting where Health Canada stated tha...bmit Hybrid eCTD regulatory submissions for New Dr...mission request. , Marlbo...
(Date:11/8/2009)..., Calif. Nov. 5, 2009 Complete Genomics, a third... announced publication of a report in the journal ...g platform, including analysis of sequence data fr...ost for these three genomes sequenced on the proof...8,005 for 87x coverage to $1,726 for 45x coverage ...
(Date:11/6/2009)... Nov. 6 Helix BioPharma ... announced that John Docherty, president and chief...n Ford,s 6th annual Investor Summit on November 10... City. Mr. Docherty will provide an overview of t...L-DOS47 and Topical Interferon Alpha-2b. The slid...
Breaking Biology Technology:intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3
...IRVINE, Calif., July 31 Alsius Corporation,(Nasda...temperature,management (IVTM(TM)) therapies for cr...l hold a conference call to discuss the Company,s,...ate. Bill Worthen,president and CEO, will host the...m. Eastern Time) on Thursday, August 7. A press re...
...Raises Full Year Financial Outlook, MELVILLE, N.Y... GTIV ), the nation,s leading provider of,compreh... second quarter,results, led by double-digit incre...mpany,s Home Health segment., (Logo: http://www....Performance highlights for the quarter ended June ...
..., Murray Grossan, MD (cre...escribes his successful treatment protocol for app...ories directly into the sinus cavities using a pul...extremely helpful for his patients who experience ...nea., http://abclocal.go.com/kabc/story?section=ne...
Other Biology Technology:Alsius Corporation to Host Second Quarter 2008 Financial Results Conference Call on August 7 2Gentiva Reports Strong Second Quarter led by Home Health Segment 2Gentiva Reports Strong Second Quarter led by Home Health Segment 3Gentiva Reports Strong Second Quarter led by Home Health Segment 4Gentiva Reports Strong Second Quarter led by Home Health Segment 5Gentiva Reports Strong Second Quarter led by Home Health Segment 6Gentiva Reports Strong Second Quarter led by Home Health Segment 7Gentiva Reports Strong Second Quarter led by Home Health Segment 8Gentiva Reports Strong Second Quarter led by Home Health Segment 9Gentiva Reports Strong Second Quarter led by Home Health Segment 10Gentiva Reports Strong Second Quarter led by Home Health Segment 11Gentiva Reports Strong Second Quarter led by Home Health Segment 12Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation 2
(Date:11/4/2009)... , Vancouver, BC - Lowly bacteria, it turns out, ...nufacturing plants around the world clean up toxic...mines, specifically RDX, were invented back in Wor... for decades. These high-energy compounds are oft...powerful version of TNT. , But with increased ...
(Date:11/4/2009)... , The University of Oklahoma at Norman has recei...hree funding agencies as part of the federal stimu...funding received by OU researchers to $23 million....or research ranging from archaeology to weather. ,...ystematic approach to matching areasof scholarly e...
(Date:11/4/2009)... , MADISON, N.J., Oct. 20 /PRNewswire-FirstCa...), the world,s leading provider of diagnostic test...the third quarter ended September 30, 2009, income...or $1.02 per diluted share, from $160 million, or ...2008. In 2008, third quarter results were reduced ...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 57017 1Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 57017 2Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 57017 3Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 57017 4NCCN Holds Oncology Research Best Practices Conference 57014 1NCCN Holds Oncology Research Best Practices Conference 57014 2NCCN Holds Oncology Research Best Practices Conference 57014 3CBC Announces Its Cosmetic Bootcamp University Program is Sold Out for New York 57011 1
...k Ridge, Ill. (December 16, 2008) A study recentl...1) estimates that eating one egg per day is respon...ary heart disease (CHD) in healthy adults. Alterna...king, obesity and physical inactivity contribute 3...n gender. This study adds to more than thirty year...
...e firemen fighting fire with fire, researchers at ...assachusetts at Amherst have found a way to fool a...g its own death. , "The basic idea is for an anti...in order to gain immunity, would require the bacte...id Gerard Wong, a professor of materials science a...
...HAM, N.C.Neuroscientists from Duke University Medi...heir brains differently than younger people when i...sociated with negative emotions. , The study, ap...cal Science , is a novel look at how brain connect...e 70, and younger adults, average age 24, were sho...
Other Biology News:New study 'pardons' the misunderstood egg 2New study 'pardons' the misunderstood egg 3Scientists fool bacteria into killing themselves to survive 2Old and young brains rely on different systems to remember emotional content 2
...ains 400 unique human proteins on a 1x3 inch nitro...s section of all cellular proteins, are arrayed in...l control proteins and a specific chip layout guar... protein microarrays are high-density protein bioc...
Product Quotation Request - Microarray Spotting Solution for Silane Coated Slides from Sigma-Aldrich
...analytical performance , When you require ease-...e, the Varian 810-MS delivers., Varian 810-M...terface/extraction optics minimize,interferences...ification. , Optimized sample introduction syst...
...-2000, except that it uses a deep-UV deuterium bul...nd comes with a shutter (controlled via a TTL sign...ungsten Halogen Light Source combines the continuo...t sources in a single optical path. The combined-s...
Biology Products: